Dr Nicholas Gollop is a pharmaceutical physician and Executive Medical Director at Novartis, where he leads cardiovascular development programmes and contributes to portfolio strategy and innovation. He has worked across clinical development, medical affairs, regulatory strategy, and product launches, with experience spanning small molecules, biologics, and gene therapies. He holds academic appointments at Kings College London and the University of Surrey. His interests include healthcare innovation and using science, data, and technology to improve patient outcomes and deliver better long-term value in healthcare systems.